Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

US FDA issues alert for sterile products made by Californian compounder

The US FDA has issued a product safety alert and recommended a compounding pharmacy cease manufacturing operations after observing unsanitary conditions at a Californian facility.

Lonza to develop production process for Benitec gene therapy Hep C candidate

Lonza has been contracted to develop a production process for a hepatitis C drug being trialled by gene silencing firm Benitec Biopharma.

Trenzyme licenses 7g per litre expression tech from JRS's Celonic

Contractor Trenzyme GmbH has licensed a CHO cell line-based expression system from Swiss firm Celonic AG in a deal designed to expand its service offering.

AmerisourceBergen will pay $2.56bn for compounder PharMEDium Healthcare

AmerisourceBergen has announced plans to buy drug compounding firm PharMEDium Healthcare Holdings from private equity group, Clayton, Dubilier & Rice.

Evotec hopeful US NCI contract will prompt more compound management deals

Evotec has been hired to manage candidate drug compounds by the US National Cancer Institute (NCI) under an agreement the CRO hopes will help it win further contracts.

BASF new efficiency drive may involve job cuts

BASF expects to reduce its workforce though natural employee turnover rather than redundancies as part of a new €1bn cost cutting plan.

Chiltern seeking metabolism expertise for new unit after hiring ex PPD exec

Got experience in endocrinology and metabolism indications R&D? Chiltern has added a new offering and says it is looking to hire.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...